These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16945500)

  • 21. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage.
    López Ramírez Y; Vivenes M; Miller A; Pulido A; López Mora J; Arocha-Piñango CL; Marchi R
    Clin Chim Acta; 2006 Dec; 374(1-2):69-74. PubMed ID: 16844105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.
    Bagheri M; Rad IA; Omrani MD; Nanbaksh F
    Syst Biol Reprod Med; 2011 Oct; 57(5):261-4. PubMed ID: 21548851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
    Mills JD; Mansfield MW; Grant PJ
    Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
    Slowik A; Dziedzic T; Pera J; Figlewicz DA; Szczudlik A
    Cerebrovasc Dis; 2005; 19(3):165-70. PubMed ID: 15644629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.
    Attié-Castro FA; Zago MA; Lavinha J; Elion J; Rodriguez-Delfin L; Guerreiro JF; Franco RF
    Thromb Haemost; 2000 Oct; 84(4):601-3. PubMed ID: 11057857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus.
    de Lange M; Andrew T; Snieder H; Ge D; Futers TS; Standeven K; Spector TD; Grant PJ; Ariëns RA
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1914-9. PubMed ID: 16763156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population.
    Cho KH; Kim BC; Kim MK; Shin BA
    J Korean Med Sci; 2002 Apr; 17(2):249-53. PubMed ID: 11961312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
    Balogh I; Szôke G; Kárpáti L; Wartiovaara U; Katona E; Komáromi I; Haramura G; Pfliegler G; Mikkola H; Muszbek L
    Blood; 2000 Oct; 96(7):2479-86. PubMed ID: 11001900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
    Butt C; Zheng H; Randell E; Robb D; Parfrey P; Xie YG
    Blood; 2003 Apr; 101(8):3037-41. PubMed ID: 12480694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity and levels of factor XIII in a Venezuelan admixed population: association with rs5985 (Val35Leu) and STR F13A01 polymorphisms.
    Vívenes M; Castro de Guerra D; Rodríguez-Larralde A; Arocha-Piñango CL; Guerrero B
    Thromb Res; 2012 Nov; 130(5):729-34. PubMed ID: 22909824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity.
    Anwar R; Gallivan L; Edmonds SD; Markham AF
    Blood; 1999 Feb; 93(3):897-905. PubMed ID: 9920838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
    Shemirani AH; Haramura G; Bagoly Z; Muszbek L
    Biochim Biophys Acta; 2006 Aug; 1764(8):1420-3. PubMed ID: 16920044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
    Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.